Which has higher earnings & valuation, GH or CI?

Cigna Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Guardant Health $982.02M 24.30 -$416.28M -$3.49 N/A Cigna Group $274.90B 0.26 $5.96B $24.17 11.21

Does the media prefer GH or CI?

In the previous week, Cigna Group had 18 more articles in the media than Guardant Health. MarketBeat recorded 24 mentions for Cigna Group and 6 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.62 beat Cigna Group's score of 0.43 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cigna Group 4 Very Positive mention(s) 6 Positive mention(s) 12 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer GH or DGX?

In the previous week, Guardant Health had 3 more articles in the media than Quest Diagnostics. MarketBeat recorded 6 mentions for Guardant Health and 3 mentions for Quest Diagnostics. Guardant Health's average media sentiment score of 0.62 beat Quest Diagnostics' score of 0.44 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Quest Diagnostics 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings & valuation, GH or LH?

Labcorp has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Guardant Health $982.02M 24.30 -$416.28M -$3.49 N/A Labcorp $13.95B 1.79 $876.50M $12.09 25.52

Does the media prefer GH or LH?

In the previous week, Guardant Health and Guardant Health both had 6 articles in the media. Guardant Health's average media sentiment score of 0.62 beat Labcorp's score of 0.41 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Labcorp 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation & earnings, GH or TEM?

Tempus AI has higher revenue and earnings than Guardant Health. Tempus AI is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Guardant Health $982.02M 24.30 -$416.28M -$3.49 N/A Tempus AI $1.27B 10.87 -$245.03M -$1.44 N/A

Does the media prefer GH or TEM?

In the previous week, Tempus AI had 7 more articles in the media than Guardant Health. MarketBeat recorded 13 mentions for Tempus AI and 6 mentions for Guardant Health. Tempus AI's average media sentiment score of 0.77 beat Guardant Health's score of 0.62 indicating that Tempus AI is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tempus AI 5 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Guardant Health (GH) Competitors

$177.80 +3.05 (+1.75%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$177.50 -0.30 (-0.17%)

As of 10/2/2026 07:54 PM Eastern

Compare

GH vs. CI, DGX, LH, TEM, and FMS

Should you buy Guardant Health stock or one of its competitors? Guardant Health's main competitors and comparable companies include Cigna Group (CI), Quest Diagnostics (DGX), Labcorp (LH), Tempus AI (TEM), and Fresenius Medical Care AG & Co. KGaA (FMS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Guardant Health compare to Cigna Group?

Guardant Health (NASDAQ:GH) and Cigna Group (NYSE:CI) are both large-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment.

Guardant Health has a beta of 1.58, meaning that its stock price is 58% more volatile than the broader market. Comparatively, Cigna Group has a beta of 0.29, meaning that its stock price is 71% less volatile than the broader market.

Guardant Health currently has a consensus target price of $188.54, suggesting a potential upside of 6.04%. Cigna Group has a consensus target price of $338.24, suggesting a potential upside of 24.85%. Given Cigna Group's higher possible upside, analysts plainly believe Cigna Group is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96
Cigna Group	0 Sell rating(s)	8 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.65

92.6% of Guardant Health shares are held by institutional investors. Comparatively, 87.0% of Cigna Group shares are held by institutional investors. 5.6% of Guardant Health shares are held by company insiders. Comparatively, 0.6% of Cigna Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Cigna Group had 18 more articles in the media than Guardant Health. MarketBeat recorded 24 mentions for Cigna Group and 6 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.62 beat Cigna Group's score of 0.43 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cigna Group	4 Very Positive mention(s)	6 Positive mention(s)	12 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cigna Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	24.30	-$416.28M	-$3.49	N/A
Cigna Group	$274.90B	0.26	$5.96B	$24.17	11.21

Cigna Group has a net margin of 2.27% compared to Guardant Health's net margin of -38.33%. Cigna Group's return on equity of 19.75% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-38.33%	N/A	-25.40%
Cigna Group	2.27%	19.75%	5.34%

Summary

Cigna Group beats Guardant Health on 9 of the 17 factors compared between the two stocks.

How does Guardant Health compare to Quest Diagnostics?

Guardant Health (NASDAQ:GH) and Quest Diagnostics (NYSE:DGX) are both large-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends.

92.6% of Guardant Health shares are held by institutional investors. Comparatively, 88.1% of Quest Diagnostics shares are held by institutional investors. 5.6% of Guardant Health shares are held by insiders. Comparatively, 0.9% of Quest Diagnostics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Guardant Health had 3 more articles in the media than Quest Diagnostics. MarketBeat recorded 6 mentions for Guardant Health and 3 mentions for Quest Diagnostics. Guardant Health's average media sentiment score of 0.62 beat Quest Diagnostics' score of 0.44 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Quest Diagnostics	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Guardant Health presently has a consensus price target of $188.54, suggesting a potential upside of 6.04%. Quest Diagnostics has a consensus price target of $237.08, suggesting a potential upside of 1.61%. Given Guardant Health's stronger consensus rating and higher possible upside, equities research analysts clearly believe Guardant Health is more favorable than Quest Diagnostics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96
Quest Diagnostics	0 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.54

Quest Diagnostics has a net margin of 9.18% compared to Guardant Health's net margin of -38.33%. Quest Diagnostics' return on equity of 16.01% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-38.33%	N/A	-25.40%
Quest Diagnostics	9.18%	16.01%	7.27%

Guardant Health has a beta of 1.58, meaning that its share price is 58% more volatile than the broader market. Comparatively, Quest Diagnostics has a beta of 0.54, meaning that its share price is 46% less volatile than the broader market.

Quest Diagnostics has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Quest Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	24.30	-$416.28M	-$3.49	N/A
Quest Diagnostics	$11.04B	2.33	$992M	$9.42	24.77

Summary

Guardant Health beats Quest Diagnostics on 9 of the 16 factors compared between the two stocks.

How does Guardant Health compare to Labcorp?

Guardant Health (NASDAQ:GH) and Labcorp (NYSE:LH) are both large-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, media sentiment, dividends, institutional ownership and earnings.

Guardant Health currently has a consensus price target of $188.54, suggesting a potential upside of 6.04%. Labcorp has a consensus price target of $337.73, suggesting a potential upside of 9.45%. Given Labcorp's higher probable upside, analysts clearly believe Labcorp is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96
Labcorp	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.75

In the previous week, Guardant Health and Guardant Health both had 6 articles in the media. Guardant Health's average media sentiment score of 0.62 beat Labcorp's score of 0.41 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Labcorp	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 95.9% of Labcorp shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by company insiders. Comparatively, 0.8% of Labcorp shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Labcorp has a net margin of 6.99% compared to Guardant Health's net margin of -38.33%. Labcorp's return on equity of 16.74% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-38.33%	N/A	-25.40%
Labcorp	6.99%	16.74%	7.81%

Guardant Health has a beta of 1.58, indicating that its stock price is 58% more volatile than the broader market. Comparatively, Labcorp has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market.

Labcorp has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	24.30	-$416.28M	-$3.49	N/A
Labcorp	$13.95B	1.79	$876.50M	$12.09	25.52

Summary

Labcorp beats Guardant Health on 9 of the 16 factors compared between the two stocks.

How does Guardant Health compare to Tempus AI?

Guardant Health (NASDAQ:GH) and Tempus AI (NASDAQ:TEM) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings.

In the previous week, Tempus AI had 7 more articles in the media than Guardant Health. MarketBeat recorded 13 mentions for Tempus AI and 6 mentions for Guardant Health. Tempus AI's average media sentiment score of 0.77 beat Guardant Health's score of 0.62 indicating that Tempus AI is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tempus AI	5 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Tempus AI has a net margin of -17.77% compared to Guardant Health's net margin of -38.33%. Guardant Health's return on equity of 0.00% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-38.33%	N/A	-25.40%
Tempus AI	-17.77%	-50.28%	-10.33%

Guardant Health presently has a consensus target price of $188.54, suggesting a potential upside of 6.04%. Tempus AI has a consensus target price of $71.05, suggesting a potential downside of 7.28%. Given Guardant Health's stronger consensus rating and higher possible upside, research analysts plainly believe Guardant Health is more favorable than Tempus AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96
Tempus AI	2 Sell rating(s)	9 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.41

Guardant Health has a beta of 1.58, indicating that its stock price is 58% more volatile than the broader market. Comparatively, Tempus AI has a beta of 3.54, indicating that its stock price is 254% more volatile than the broader market.

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 24.2% of Tempus AI shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by insiders. Comparatively, 24.3% of Tempus AI shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Tempus AI has higher revenue and earnings than Guardant Health. Tempus AI is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	24.30	-$416.28M	-$3.49	N/A
Tempus AI	$1.27B	10.87	-$245.03M	-$1.44	N/A

Summary

Tempus AI beats Guardant Health on 9 of the 17 factors compared between the two stocks.

How does Guardant Health compare to Fresenius Medical Care AG & Co. KGaA?

Guardant Health (NASDAQ:GH) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, risk and institutional ownership.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	24.30	-$416.28M	-$3.49	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.93	11.54

In the previous week, Guardant Health had 3 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 6 mentions for Guardant Health and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.70 beat Guardant Health's score of 0.62 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Guardant Health presently has a consensus price target of $188.54, suggesting a potential upside of 6.04%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $23.68, suggesting a potential upside of 6.29%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.58

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to Guardant Health's net margin of -38.33%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-38.33%	N/A	-25.40%
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%

Guardant Health has a beta of 1.58, suggesting that its stock price is 58% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.74, suggesting that its stock price is 26% less volatile than the broader market.

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Fresenius Medical Care AG & Co. KGaA beats Guardant Health on 9 of the 17 factors compared between the two stocks.

Get Guardant Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GH vs. The Competition

Export

Metric	Guardant Health	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$23.45B	$9.59B	$7.14B	$13.17B
Dividend Yield	N/A	2.61%	2.53%	16.78%
P/E Ratio	-50.95	34.21	275.68	26.04
Price / Sales	20.17	5.39	662.25	102.14
Price / Cash	N/A	120.59	77.60	51.75
Price / Book	-225.06	5.15	10.93	6.31
Net Income	-$416.28M	$315.68M	$3.51B	$362.16M
7 Day Performance	0.31%	-2.59%	-2.00%	-1.66%
1 Month Performance	10.41%	-3.19%	-6.15%	-4.50%
1 Year Performance	182.94%	7.93%	7.44%	2.06%

Guardant Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GH Guardant Health	2.1758 of 5 stars	$177.80 +1.7%	$188.54 +6.0%	+189.3%	$23.45B	$1.18B	N/A	2,506	Analyst Forecast
CI Cigna Group	4.9365 of 5 stars	$271.66 -0.1%	$337.10 +24.1%	-8.8%	$71.88B	$274.90B	11.24	67,700	Analyst Forecast
DGX Quest Diagnostics	3.8283 of 5 stars	$237.60 +0.5%	$237.08 -0.2%	+29.0%	$26.08B	$11.04B	25.22	57,000
LH Labcorp	4.0666 of 5 stars	$309.85 +0.1%	$337.73 +9.0%	+10.6%	$25.11B	$13.95B	25.63	71,000
TEM Tempus AI	1.7973 of 5 stars	$85.08 +0.1%	$69.63 -18.2%	-14.2%	$15.34B	$1.27B	N/A	3,800	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GH) was last updated on 10/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Guardant Health (GH) Competitors

GH vs. CI, DGX, LH, TEM, and FMS

How does Guardant Health compare to Cigna Group?

Summary

How does Guardant Health compare to Quest Diagnostics?

Summary

How does Guardant Health compare to Labcorp?

Summary

How does Guardant Health compare to Tempus AI?

Summary

How does Guardant Health compare to Fresenius Medical Care AG & Co. KGaA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GH vs. The Competition

Guardant Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Guardant Health (GH) Competitors

GH vs. CI, DGX, LH, TEM, and FMS

How does Guardant Health compare to Cigna Group?

Which has more risk & volatility, GH or CI?

Do analysts rate GH or CI?

Do institutionals & insiders hold more shares of GH or CI?

Does the media prefer GH or CI?

Which has higher earnings & valuation, GH or CI?

Is GH or CI more profitable?

Summary

How does Guardant Health compare to Quest Diagnostics?

Do insiders & institutionals hold more shares of GH or DGX?

Does the media prefer GH or DGX?

Do analysts rate GH or DGX?

Is GH or DGX more profitable?

Which has more volatility & risk, GH or DGX?

Which has preferable valuation & earnings, GH or DGX?

Summary

How does Guardant Health compare to Labcorp?

Do analysts recommend GH or LH?

Does the media prefer GH or LH?

Do insiders and institutionals hold more shares of GH or LH?

Is GH or LH more profitable?

Which has more volatility & risk, GH or LH?

Which has preferable earnings & valuation, GH or LH?

Summary

How does Guardant Health compare to Tempus AI?

Does the media prefer GH or TEM?

Is GH or TEM more profitable?

Do analysts prefer GH or TEM?

Which has more risk and volatility, GH or TEM?

Do insiders & institutionals hold more shares of GH or TEM?

Which has stronger valuation & earnings, GH or TEM?

Summary

How does Guardant Health compare to Fresenius Medical Care AG & Co. KGaA?

Which has better earnings & valuation, GH or FMS?

Does the media prefer GH or FMS?

Do analysts rate GH or FMS?

Is GH or FMS more profitable?

Which has more risk and volatility, GH or FMS?

Do institutionals and insiders hold more shares of GH or FMS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GH vs. The Competition

Guardant Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools